{"id":"https://openalex.org/W3655396","doi":null,"title":"Short and long term intraocular pressure changes after intravitreal injections of triamcinolone acetonide and bevacizumab in diabetic macular edema","display_name":"Short and long term intraocular pressure changes after intravitreal injections of triamcinolone acetonide and bevacizumab in diabetic macular edema","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W3655396","mag":"3655396"},"language":"en","primary_location":{"id":"mag:3655396","doi":null,"is_oa":false,"landing_page_url":"https://www.rmj.org.pk/?mno=161760","pdf_url":null,"source":{"id":"https://openalex.org/S2764387784","display_name":"Rawal Medical Journal","issn_l":"0303-5212","issn":["0303-5212"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4320800574","host_organization_name":"Pakistan Medical Association","host_organization_lineage":["https://openalex.org/P4320800574"],"host_organization_lineage_names":["Pakistan Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Rawal Medical Journal","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W3655396"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045553174","display_name":"Mahmood Ali","orcid":"https://orcid.org/0000-0003-0963-9014","observed_orcids":["https://orcid.org/0000-0003-0963-9014"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mahmood Ali","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0963-9014","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Furqan Ahmad Khan","orcid":"https://orcid.org/0000-0001-9655-4961","observed_orcids":["https://orcid.org/0000-0001-9655-4961"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Furqan Ahmad Khan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9655-4961","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075790084","display_name":"Sarah Zafar","orcid":"https://orcid.org/0000-0002-0544-6832","observed_orcids":["https://orcid.org/0000-0002-0544-6832"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarah Zafar","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0544-6832","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5020970353","display_name":"Farah Akhtar","orcid":"https://orcid.org/0000-0002-0285-6529","observed_orcids":["https://orcid.org/0000-0002-0285-6529"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Farah Akhtar","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0285-6529","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.00016492,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":95},"biblio":{"volume":"39","issue":"4","first_page":"443","last_page":"445"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.00930000003427267,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intraocular-pressure","display_name":"intraocular pressure","score":0.8939999938011169},{"id":"https://openalex.org/keywords/triamcinolone-acetonide","display_name":"triamcinolone acetonide","score":0.9340000152587891},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/intravitreal-injection","display_name":"intravitreal injection","score":0.9409999847412109},{"id":"https://openalex.org/keywords/diabetic-macular-edema","display_name":"diabetic macular edema","score":0.9980000257492065},{"id":"https://openalex.org/keywords/elevated-intraocular-pressure","display_name":"intraocular pressure elevation","score":0.5889999866485596},{"id":"https://openalex.org/keywords/corticosteroids","display_name":"corticosteroids","score":0.6330000162124634},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9800000190734863}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9665066003799438},{"id":"https://openalex.org/C2776251621","wikidata":"https://www.wikidata.org/wiki/Q4673280","display_name":"Acetonide","level":3,"score":0.7250065803527832},{"id":"https://openalex.org/C2781092963","wikidata":"https://www.wikidata.org/wiki/Q650050","display_name":"Intraocular pressure","level":2,"score":0.7185965180397034},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.6990126967430115},{"id":"https://openalex.org/C2778903070","wikidata":"https://www.wikidata.org/wiki/Q2211240","display_name":"Triamcinolone acetonide","level":2,"score":0.6604018807411194},{"id":"https://openalex.org/C2985127711","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic macular edema","level":4,"score":0.5995471477508545},{"id":"https://openalex.org/C2780347916","wikidata":"https://www.wikidata.org/wiki/Q1813737","display_name":"Macular edema","level":3,"score":0.5976223349571228},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.5836615562438965},{"id":"https://openalex.org/C2779829184","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic retinopathy","level":3,"score":0.38458549976348877},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.26256367564201355},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2233603596687317},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.18437150120735168},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.07666704058647156},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3655396","doi":null,"is_oa":false,"landing_page_url":"https://www.rmj.org.pk/?mno=161760","pdf_url":null,"source":{"id":"https://openalex.org/S2764387784","display_name":"Rawal Medical Journal","issn_l":"0303-5212","issn":["0303-5212"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4320800574","host_organization_name":"Pakistan Medical Association","host_organization_lineage":["https://openalex.org/P4320800574"],"host_organization_lineage_names":["Pakistan Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Rawal Medical Journal","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4413949645","https://openalex.org/W2109477235","https://openalex.org/W2032687057","https://openalex.org/W1982460180","https://openalex.org/W2312690398","https://openalex.org/W2330076147","https://openalex.org/W2082681639","https://openalex.org/W2045569104","https://openalex.org/W2756795333"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"compare":[2],"the":[3,104],"short":[4],"and":[6,18,39,67,80,91,114],"long":[7],"term":[8],"intraocular":[9],"pressure":[10],"changes":[11],"after":[12,83],"intravitreal":[13,63,70],"injections":[14],"of":[15,103],"triamcinolone":[16,64],"acetonide":[17,65],"bevacizumab":[19,71],"in":[20,100,123],"diabetic":[21,57],"macular":[22,58],"edema":[23],"cases":[24],"presenting":[25],"at":[26,78,110],"Al-Shifa":[27],"Trust":[28],"Eye":[29],"Hospital,":[30],"Rawalpindi.\r\nStudy":[31],"Design:":[32],"A":[33],"hospital":[34],"based":[35],"randomized":[36],"clinical":[37],"trial.\r\nSubjects":[38],"Methods:":[40],"The":[41],"study":[42],"was":[43,74,107],"conducted":[44],"from":[45,127],"01":[46],"Jan":[47],"2012":[48,52],"to":[49],"31st":[50],"December":[51],"on":[53,89],"60":[54],"patients":[55],"with":[56,62,69],"edema;":[59],"30":[60,68],"injected":[61],"(IVTA)":[66],"(IVB).":[72],"IOP":[73,102,122,132],"recorded":[75,88],"before":[76],"injection,":[77],"1week":[79],"6":[81,119],"weeks":[82],"injections.":[84],"All":[85],"findings":[86],"were":[87,93],"proformas":[90],"results":[92],"analyzed":[94],"using":[95],"SPSS":[96],"13.0.":[97],"\r\nResults:":[98],"Difference":[99],"mean":[101,121,131],"two":[105],"groups":[106],"not":[108],"significant":[109],"base":[111,129],"line":[112,130],"(p=0.765)":[113],"1":[115],"week":[116],"(p=0.560).":[117],"At":[118],"weeks,":[120],"IVTA":[124],"significantly":[125],"raised":[126],"its":[128],"(paired":[133],"sample":[134],"t":[135],"test,":[136],"p":[137]},"counts_by_year":[{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}